Turan Itil, Cofounder of IPEG has passed away

Turan M. Itil, M.D.


an obituary by May Fink

Turan Itil 1961 

Turan Itil at age 83 in New York

In 1929 Hans Berger, a German sanitarium psychiatrist, recorded the brain's electrical rhythms from the intact scalp of his daughter and a laboratory assistant, reporting that the rhythms were altered with arithmetic tests, sleep, and morphine, cocaine, and chloroform. During the same years that he worked, new treatments for the psychiatric ill of insulin coma, convulsive therapy and leucotomy were introduced. Interest in EEG was galvanized among psychiatrists who sought to understand the mechanism of these treatments.
When chlorpromazine and imipramine were introduced to the clinic, Turan Itil was among the first to study their effects on the EEG. At the CINP meeting in Rome in 1958, our independent reports were so similar that each could have used the other's slides and data.
In 1964 he established the EEG Laboratory at the Missouri Institute of Psychiatry in St. Louis using newly developed digital computer methods to measure EEG changes. We developed reliable quantitative methods to predict the clinical applications of putative psychoactive drugs, to separate clinically active from inactive substances, and to suggest dosage ranges.
In 1972 he was asked to profile GB-94 (mianserin), a new agent developed by Organon scientists. He found the EEG patterns in human volunteers and patients identical to those of imipramine. His report conflicted with predictions made by the Organon pharmacologists in their animal models. Based on Turan's prediction, clinical trials did show clinical antidepressant activity and mianserin was then successfully marketed as Tolvon, verifying the usefulness of the pharmaco-EEG prediction model.
Were the EEG effects of psychoactive substances in animals predictive of their effects in man? Pharmacologists opined that the EEG changes induced by drugs in animal trials were dissociated from behavior, not predictive of human drug effects, challenging pharmaco-EEG science. By1966 presentations at the CINP in Washington showed that EEG and behavior were associated in man, and that EEG studies of potential psychoactive medicines could be used to predict human applications. This critical determination established pharmaco-EEG as a human science.
Throughout his life Turan was at the heart of this science. He described the effects of natural and synthetic hormones, psychostimulants, and cognitive enhancers. In his later years he established outpatient clinics assessing dementia by EEG and computerized neuropsychologic tests.
He was a founder of the International Pharmaco-EEG Group (IPEG), an active scientific member of ACNP and CINP and numerous other EEG and psychopharmacology societies. Werner Herrmann in Berlin, Bernd Saletu in Vienna, Masami Saito in Osaka, and Sevket Akpinar in Ankara, each a leader in pharmaco-EEG science, were his students. Turan was consultant and lead scientist on projects of the World Health Organization.
Turan Itil was born in Bursa, Turkey on August 12, 1924. He received the M.D. degree from Istanbul University in 1948 and moved to the University of Tübingen in Germany for training in neurology. In 1953 he joined the faculty at the University of Erlangen with EEG and psychopharmacology the center of his research. After a decade in St. Louis, he moved to New York Medical College and established the HZI Research Center Laboratory in Tarrytown New York.
He was a vibrant, enthusiastic, and warm-hearted man. He played intensely, enjoyed ping-pong, billiards and roulette. He supported friends and colleagues enthusiastically. He adjusted to the American culture but on retirement he returned to his family in Turkey. He died at his country home on April 29, 2014 at age 89. He and his wife Ellen had two children, Kurt and Yasmin. He leaves an extended family in Turkey and New York, friends and students around the world, and a unique body of psychopharmacology science.

Posted on 5 jun 2014


EEG research and Corona Crisis 2020

Many EEG researchers are not able to perform assessment of EEG recordings in their labs due to the pandemic Covid-19 crisis. Arnaud Delorme and Scott Makeig, heads of the EEGlab platform, propose several things to do dring these hard times to prevent the lockdown of EEG research Read their hints here.

Read more

Abstract Book available

 The complete Abstract Book for the Zurich 2018 Meeting is available now

Read more

Final Program

The final program for the IPEG Meeting November 21st-25th in Zurich is ready for download HERE

Read more